IL98637A - Apparatus and process for metering powder - Google Patents

Apparatus and process for metering powder

Info

Publication number
IL98637A
IL98637A IL98637A IL9863791A IL98637A IL 98637 A IL98637 A IL 98637A IL 98637 A IL98637 A IL 98637A IL 9863791 A IL9863791 A IL 9863791A IL 98637 A IL98637 A IL 98637A
Authority
IL
Israel
Prior art keywords
powder
carrier
charged
fibres
suspension
Prior art date
Application number
IL98637A
Other languages
Hebrew (he)
Other versions
IL98637A0 (en
Inventor
Arun R Gupte
Dieter Hochrainer
Gerhard Poss
Juergen Wittekind
Bernd Zierenberg
Adolf Knecht
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4020571A external-priority patent/DE4020571A1/en
Priority claimed from DE19914102793 external-priority patent/DE4102793A1/en
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of IL98637A0 publication Critical patent/IL98637A0/en
Publication of IL98637A publication Critical patent/IL98637A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A61M15/0046Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
    • A61M15/0051Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged on a tape, e.g. strips
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65BMACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B3/00Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B3/003Filling medical containers such as ampoules, vials, syringes or the like
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65BMACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B3/00Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B3/26Methods or devices for controlling the quantity of the material fed or filled
    • B65B3/34Methods or devices for controlling the quantity of the material fed or filled by timing of filling operations
    • B65B3/36Methods or devices for controlling the quantity of the material fed or filled by timing of filling operations and arresting flow by cut-off means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/02Gases
    • A61M2202/0225Carbon oxides, e.g. Carbon dioxide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/06Solids
    • A61M2202/064Powder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/07General characteristics of the apparatus having air pumping means
    • A61M2205/071General characteristics of the apparatus having air pumping means hand operated
    • A61M2205/073Syringe, piston type
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/07General characteristics of the apparatus having air pumping means
    • A61M2205/071General characteristics of the apparatus having air pumping means hand operated
    • A61M2205/075Bulb type
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/82Internal energy supply devices
    • A61M2205/8218Gas operated
    • A61M2205/8225Gas operated using incorporated gas cartridges for the driving gas

Abstract

In order to produce an aerosol, a velvety or velours-like material charged with a powder is brought into an air current.

Description

ηρηκ ϊΐ-Ρ»ί> η^ηηι ipnn Apparatus and process for metering powder BOEHRINGER INGELHEIM KG ; C. 83728 - l - Apparatus and process for metering powder The invention relates to an apparatus and - a ..process for metering small amounts of finely divided powder.
Small amounts of finely divided, preferably micronised powder are used in particular, for therapeutic purposes, mainly in aerosol formulations for the treatment by inhalation of respiratory complaints such as asthma.
Powders.of this kind are conveyed to the patient's lungs in amounts which are usually well below 50 mg per inhalation. It has been found that the particles of active substance should be less than 10 μτα. in size to ensure that they penetrate deep into the lungs.
However, this does not rule out the use of some larger particles in the preparations, particularly for any excipients. If particles of different sizes are used, a significant difference in size is sometimes even desirable or is in any case not harmful; see for example DE-OS 17 92 207.
Two main methods have been developed as alternatives for administering fine powders without the aid of propellant gases in respiratory tract therapy.
One method makes use of hard gelatine capsules each of which contains a dose of active substance and possibly also excipients, whilst the other, using a measuring chamber, removes a specific amount of powder - from a storage container and mixes it with the air breathed in. Devices for both methods have been described in large numbers, see for example DE-OS 23 46 914 and EP-A 166 294.
The granted US patent 390 475 disclose a snapper for inhalation devices in which the desired quantum of a medicated powder is inclosed within an envelope of any suitable porous fabric so as to form a ball. This device does not allow to apply a controlled metered dose of a high active pharmaceutical drug.
US Patent 137,093 describes an apparatus for the cure of asthma comprising a brush for releasing the medicine. This inhalation device does not allow the controlled application of a metered dose of a medicament.
US Patent No. 361 599 claims a method for applying an antiseptic agent being the medium of an impalpable dust escaping from its confinement through the cloth tissue of the bag when struck or snapped suddenly. This method does not give the safety for a metered dose of an active ingredient.
The present invention now provides a new method of administering fine powders. In our method, the ease of manufacture of carriers charged with active substance is advantageously combined with accuracy of metering and - 2 -the possibility of producing an aerosol suitable for inhalation by simple means.
According to the invention, a velour or velvet-like carrier material is charged with powder which is to be metered and the desired amount of powder is blown from the carrier material by means of a gas jet, optionally after mechanical loosening, preferably using an air jet of suitable intensity. When used for inhalation, the powder released is mixed with the air to be inhaled, optionally via an inhalation device such as the one described for example in German Utility Model 89 08273.
When the dry powder is spread into the velour material, the movement of the fibres under the doctor blade causes a preliminary break-up. The particles are then in a very loose state and are correspondingly less inclined to clump together. When the powder is applied by means of a suspension, this preliminary break-up is achieved by running an edge over the powder, so that once again only some of the energy for the breaking-up has to be supplied by the gas jet. Moreover, the previously broken up particles present a large surface area for contact with the gas jet, which again has a favourable effect on dispersal.
The carrier comprises a substantially planar material on which thin fibres are provided. The fibres are secured at one end or at their centre on or in the carrier, the free end or the two free ends being directed upwardly and the carrier and fibres predominantly forming angles of 45 to 90°, more particularly 60 to 90° with one another. The material which carries the fibres may be, for example, paper, plastics film or a textile fabric; the fibres may be natural or synthetic, e.g. cotton, wool, silk, viscose, perIon, nylon or polyacrylic.
The fibres are generally up to about 3 mm long, preferably up to about 1 mm long. They should not be too matted, so as to try and ensure that the powder - 3 -applied, which is essentially situated or embedded between the fibres, can be blown out again relatively easily. The lower limit for the length of the fibres is about 0.1 mm. Generally, the length of the fibres should be such that the powder applied can be accommodated in the desired quantities per unit of surface area.
Accordingly, a carrier material with longer fibres may be appropriate for relatively large quantities of powder per unit of surface area, whereas, for very small quantities of powder per unit of surface area, shorter fibres are usable or, even, advantageous. The quantity of powder which can be applied per unit of surface area depends mainly on the nature (density) of the powder and its compaction, as well as the carrier material used.
If the powder is to be administered by inhalation, care must however be taken to ensure that the dispersal of the powder in the gas or air jet used is not affected by excessive compaction.
The number of fibres per unit of surface area may vary considerably. Various commercially available carriers have proved suitable (velour-film, velvet, nicki) . These products also provide a guide to the suitable fibre density of other carriers. The fibre thickness also varies within wide limits. Generally, fibres with a diameter of from 0.002 to 0.05, preferably 0.004 to 0.03 mm are used. The velvet-like carrier itself may also be attached, e.g. by glueing, to a stiff layer. It is also possible to attach an absorbent under-layer.
The carrier may therefore be flexible or rigid and of any desired shape, rectangular or circular for example. Preferably, the carrier is in the form of a strip. This may be charged with the powder over its entire surface or over individual areas. In the latter case, the strip may be charged with the powder by means of a template over small individual areas, e.g. in the form of circular areas a few millimetres in diameter and clearly spaced apart, so that when the powder is blown out from one of these areas the powder on the neighbouring areas remains unaffected.
Thus, the dose can be accurately fixed by means of the quantity of powder on each of the small charged areas.
If the entire surface of the carrier is coated with powder, the quantity of powder which is blown out can simply be determined by the size of the area exposed to the gas jet during each separate removal operation and defined, for example, by means of a mask. However, a mask is not essential. It has been found, in fact, that the quantity of powder blown downwards from the uniformly charged carrier by means of the gas jet is substantially constant. Consequently, the quantity of powder dispersed can be readily regulated by the intensity of the gas jet and the geometry of the nozzle. In order to protect the layer of powder it may be appropriate to cover or laminate the carrier with a plastics film, for example, in such a way that only that part of the carrier from which powder is to be taken is exposed. Particularly in the case of moisture-sensitive powders, an aluminium lamination on both sides might be considered. Finally, it is also possible to use carriers, e.g. strips, in which there are alternating areas filled with fibres and smooth areas.
According to a further feature of the invention, we provide a process for producing a carrier as described above in which the powder is uniformly distributed on the carrier and is incorporated in the fibre layer in one or more steps using a doctor blade or the powder is applied to the velvet- or velour-like carrier in the form of a small amount of a suspension and the suspending agent is evaporated off.
In order to charge the carrier using one embodiment, first of all a layer of powder 1 to 2 mm - 5 -high is distributed as uniformly as possible thereon (in the case of highly effective pharmaceutical powders and in the case of carriers with very short fibres the layer may be considerably thinner) . The powder is pressed into the strip by means of a doctor blade and excess powder is wiped away. This process is repeated once or several times, as necessary, with the doctor blade being set progressively lower. As a result of the movement of the fibres under the pressure of the doctor blade, the agglomerated areas of powder are broken up.
If only certain parts of the carrier are to be charged, the carrier may be covered, for example, with a template, e.g. a suitably perforated film. If the powder is then applied as described above, the carrier will be charged with it only at those points where the perforations are located.
In another embodiment, the powder may also be applied to the carrier in the form of a suspension. In the case of pharmaceutical compositions for inhalation, the dosage of active substance is generally so small that the quantity of active substance contained in one drop of suspension is sufficient. One drop of the suspension is then applied at the desired spacing from the next drop. The spacing is selected so that the spot of powder which remains after evaporation of the suspension agent is clearly separated from the adjacent spot. The aim is to be able to separate only the exact quantity of powder applied in one drop from the carrier when the powdered active substance is transferred into the stream of air inhaled.
It is particularly satisfactory to charge the carrier with an accurately metered quantity of powder over a small area using a suspension.
The suspending agents used may be liquid organic compounds in which the powder to be applied does not dissolve readily and which can be eliminated as completely as possible. - 6 - Examples of suspending agents of this kind which are selected in accordance with the solubility characteristics of the substance or mixture of substances to be suspended include dichloromethane, ethyl acetate, 1, 1, l-trichloroethane or petrol (e.g. the fraction 60/95 or 80/110) . As a rule, suspension adjuvants such as lecithin are added to the suspension. The solids content in the suspension is usually between 3 and 30 percent by weight, preferably from 5 to 25 percent by weight; the quantity of suspension adjuvants varies between about 0.5 and 3 percent by weight, based on the solids.
The carriers and suspension should be such that the particles of powder are left behind at the point where the drop penetrates into the carrier, whilst the suspending agent spreads out and then evaporates. The evaporation can be promoted by pressure reduction and/or by heating.
The material from the dried drop of suspension cannot generally be released and dispersed simply by means of a jet of air. However, if the fibres of the carrier are moved, e.g. by running an edge over them the bonds between the particles of powder are broken up again and the powder is "activated". The individual particles which adhere to one another or to the fibres of the carrier with only slight adhesive force after activation can then be released by means of an air jet and dispersed, to a large extent, into the lungs.
Instead of releasing the loosened powder from the carrier by means of a jet of air, it is also possible to loosen it by running an edge over it or by brushing, immediately before or while the flow of breathed-in air is passing the carrier, and thereby transferring the powder into the air which is breathed in.
Apart from the high degree of accuracy of metering, the application of a drop of suspension has the further advantage over the application of dry powder that the - 7 -powder is protected from being released by acceleration (impact, vibrations) by the incrustation. The activation by running along an edge should only be carried out immediately before the powder is released for inhalation.
The invention may be more particularly understood with reference to the accompanying drawings. These are by way of example only and in the drawings: Figure 1 shows diagrammatically an apparatus according to the invention for applying the drop of suspension; In Figure 2 shows cross-section of part of an electronic valve represented in Figure 1.
Figures 3 and 4 show diagrammatically front and side views of a simple device in which carriers charged according to the invention may be used.
In Figure 1, suspension 1 is initially in storage container 2. From there it flows through line 3 to a magnetic valve 4 and passed the valve surfaces through line 5 into storage container 6. Details of the magnetic valve are illustrated in Figure 2. In the resting position plunger 7 seals off the inlet port of line 8 from which the suspension is applied to carrier 11. At or around the sides, the suspension is able to flow past the plunger from the line 3 to the line 5.
When the plunger is pulled back by an electromagnet, it exposes the opening so that the suspension can reach the carrier 11. The suspension is pumped out of the container 6 by means of pump 9 into the storage container 2. To ensure that the suspension in storage container 2 is always at the same level, there is a connecting line 10 between these two storage containers, through which suspension can flow from storage container 2 into storage container 6 when the liquid level is higher than the entry port of this connecting line. The cross-section of the lines 3 and 10 is made so small that the volume flow of suspension flowing through the - 8 -two lines is less than the volume flow delivered by the pump 9. In the storage containers 2 and 6 are stirrers which keep the particles constantly suspended. For uniform metering, the magnetic valve 4 is controlled by an electronic timer (not shown) .
A simple device in which carriers charged according to the invention can be used is diagrammatically shown in Figures 3 and 4. The main constituents are two bobbins, one of which receives the charged strip whilst the other receives the used strip. The strip is guided over a panel, whilst being guided passed an edge to activate the powder. Here, the jet of gas or air makes contact with the strip and carries the powder along. The jet is generally released at a time when air is being breathed in through the mouthpiece. It is advisable to actuate the stream of gas or air by means of the air breathed in so as to coordinate the dispersal of the powder with the inhalation of the process.
Figure 3 shows an inhalation device viewed from in front. A carrier strip 12 with the powder, which is applied in individual dots at regular intervals on the strip, is unwound from bobbin 13 and, once empty, wound onto bobbin 14. By means of a transporting mechanism constructed in conventional manner, the strip is wound on, on each actuation of the device, by an amount such that a new spot arrives on flat surface 15. The flat surface 15 is located in a mouthpiece 16 through which the patient inhales. The slot through which the carrier strip 12 is guided into the mouthpiece is somewhat narrower than the thickness of the carrier strip 12.
The upper boundary of the slot is constructed as an edge for activating the powder. Air is passed onto the dot of powder through a nozzle 21 from a cylinder 17 in which there is a piston subjected to spring pressure with a handle 18. The spring which urges the piston towards the flat surface 15 is biased by pulling the handle 18. The dispersing step is prepared by means of a locking mechanism 19 which can be released by pressing knob 20. Whilst breathing in through the mouthpiece 16 the patient presses the knob 20 and thus ensures that the piston propels the quantity of air contained in the cylinder through the nozzle onto the dot of powder, so that the powder is dispersed in the air breathed in.
Figure 4 diagrammatically shows the apparatus from the side, the mouthpiece 16 being shown in section. The nozzle 21 (not shown in Figure 4) guides the jet of air out of the cylinder 17 onto the dot of powder.
The bobbins with the carrier are in this case contained in a cassette similar to that used in cassette recorders. Their movement is advantageously coupled with the movement of the handle 18, so that, each time the piston is put under tension, the carrying strip is moved on until the next dot reaches the flat surface 15. - 10 - Example of the application of the pharmaceutical composition as a suspension; A suspension of micronised fenoterol (proportion of fenoterol: 10 percent by weight) in dichloromethane with the addition of (0.1 percent by weight) lecithin was applied to velvet with a fibre length of 1.2 mm over the basic fabric, dropwise at spacings of about 10 mm and then dried. The powder was then activated by running an edge over it and blown out of the carrier with a gentle jet of compressed air.
The inhalable portion of the particles (particle diameter < 5.8 τα) was 41.4% of the dosage expelled.
A relatively small amount of gas, e.g. 10 cc or air, forced through a 0.5 mm diameter nozzle, is sufficient to disperse (blow out) the powder.
The gas jet required for dispersal can be produced in various ways, e.g. using a cylinder provided with a nozzle out of which air is forced by a spring-operated piston, or by means of conventional small C02 containers which can be used to generate pressure.
Instead of the cylinder and spring it is also possible to use a bellows or a C02 cartridge of conventional construction 'which releases a few cc of C02 every time the device is used, in order to generate a gas current, as mentioned above. The C02 is then again guided through a nozzle onto the carrier surface coated " with powder. The volume of gas needed to disperse a quantity of powder required for therapeutic purposes is generally 3 to 20 cc (under normal conditions) .
Nozzles are used which have a mouth shaped to suit the type of carrier. In the case of circular dots of powder, the nozzle has a small, preferably circular aperture. In the case of larger, powder-coated carrier surfaces, a slot-shaped or rectangular nozzle may be - 11 -more appropriate. In this case, a larger quantity of gas is used, if necessary, in order to ensure the required speed of outflow.
The accuracy of metering was measured in a series of tests in which either (tests 1, 2, 3) a carrier strip was continuously coated by the application of dry powder and a sharply defined section of the strip was investigated in each case or else a strip was used in which only certain places had a coating of powder.
The following surface coatings and relative standard deviations were found: Material Surface Relative standard covering deviation 1. Velour-film 6.6 mg/cm 6.3% 2. Velvet 2.2 mg/cm2 6.0% 3. Nicki 5.4 mg/cm2 6.2-' 4. Velour-film with individual circular dots of powder* 2.1 mg/dot 11.2·' * When the powder was applied the carrier was covered with a perforated film. The perforations were 4 mm in diameter and spaced 10 to 15 mm apart. By improving the charge, the standard deviation could be reduced still further in subsequent tests.
For virtually complete dispersal on blowing out the powder, a relatively small amount of gas is sufficient, e.g. 10 cc of air which is forced through a 0.8 mm diameter nozzle (in the case of the dots of powder according to test number 4) . Excellent break-up is found.
As was established by means of the Andersen impactor using micronised fenoterol, 40% of the particles of the dosage expelled were in the particle size range below 5.8 μιη.

Claims (14)

- 12 - Claims
1. A carrier charged with a powdered pharmaceutical preparation which comprises a substantially flat material on which fibres are arranged in a velvet- or velour-like manner and the powder is incorporated between the fibres.
2. A powder-charged carrier as claimed in claim 1, in which the fibre length is 0.1 to 3 mm.
3. A powder-charged carrier as claimed in claim 1 or claim 2, in which the layer which carries the fibres is flexible.
4. A powder-charged carrier as claimed in claim 1 or claim 2, in which the layer which carries the fibres is rigid.
5. A powder-charged carrier as claimed in any of claims 1 to 4, in which the entire carrier surface is uniformly charged with powder.
6. A powder-charged carrier as claimed in any of claims 1 to 4 , in which only partial areas of the carrier are charged with powder, the individual charged partial areas of the carrier each containing a single dose of a pharmaceutical substance.
7. A powder-charged carrier as claimed in any of claims 1 to 6, in which the carrier is provided with a protective film on the powder-charged side or on both sides.
8. A powder-charged carrier substantially as hereinbefore described and with reference to the
9. Example. 98637/2 - 13 - 9. A process for producing a carrier as claimed in any of claims 1 to 8, wherein the powder is uniformly distributed on the carrier and is incorporated in the fibre layer in one or more steps using a doctor blade.
10. A process for producing a carrier as claimed in any of claims 1 to 8, wherein the powder is applied to the velvet- or velour-like carrier in the form of a small amount of a suspension and the suspending agent is evaporated off.
11. A process as claimed in claim 9 or claim 10 substantially as hereinbefore described and with reference to the Example.
12. A process for metering powders for inhalation, wherein a desired amount of powder is blown from a carrier as defined in any of claims 1 to 8 by means of a gas jet and dispersed in air to be inhaled.
13. A process as claimed in to claim 12, the area of the carrier from which the powder is to be blown is defined by a mask.
14. A process for metering powders for inhalation, wherein single doses of the powder are applied to a carrier as defined in any of claims 1 to 8 in the form of a suspension, are activated after drying, and blown from the carrier by means of a gas jet and dispersed in the air to be inhaled. For the Applicants EINHOLO COHN AND PARTNERS
IL98637A 1990-06-28 1991-06-27 Apparatus and process for metering powder IL98637A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4020571A DE4020571A1 (en) 1990-06-28 1990-06-28 Device for dosing small quantities of powder esp. for asthma - powder is held between fibres of velvet-like material and is delivered, e.g. as medication into patients inhaled breath, by jet of air
DE19914102793 DE4102793A1 (en) 1991-01-31 1991-01-31 Medication powder-dosing carrier

Publications (2)

Publication Number Publication Date
IL98637A0 IL98637A0 (en) 1992-07-15
IL98637A true IL98637A (en) 1998-01-04

Family

ID=25894544

Family Applications (1)

Application Number Title Priority Date Filing Date
IL98637A IL98637A (en) 1990-06-28 1991-06-27 Apparatus and process for metering powder

Country Status (24)

Country Link
EP (1) EP0536232B1 (en)
JP (1) JP3307389B2 (en)
KR (1) KR0179375B1 (en)
AT (1) ATE127353T1 (en)
AU (1) AU661274B2 (en)
CA (1) CA2086123C (en)
CZ (1) CZ283510B6 (en)
DE (1) DE59106431D1 (en)
DK (1) DK0536232T3 (en)
ES (1) ES2078530T3 (en)
FI (1) FI104410B (en)
GR (1) GR3017782T3 (en)
HU (1) HU216129B (en)
IE (1) IE69035B1 (en)
IL (1) IL98637A (en)
NO (1) NO304295B1 (en)
NZ (1) NZ238783A (en)
PL (1) PL165973B1 (en)
PT (1) PT98112B (en)
RU (1) RU2068274C1 (en)
SI (1) SI9111110B (en)
UA (1) UA27765C2 (en)
WO (1) WO1992000115A1 (en)
YU (1) YU48708B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048857A (en) * 1989-10-17 2000-04-11 Ellinwood, Jr.; Everett H. Dosing method of administering medicaments via inhalation administration
DE4142238A1 (en) * 1991-12-20 1993-06-24 Boehringer Ingelheim Kg POWDER INHALATOR WITH POWDER SUPPORT FROM REGULAR MICROSTRUCTURES
SE9203570D0 (en) * 1992-11-27 1992-11-27 Astra Ab INHALES FOR MULTIPLE USE
US5388572A (en) * 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
US5388573A (en) * 1993-12-02 1995-02-14 Tenax Corporation Dry powder inhalator medicament carrier
US5503869A (en) * 1994-10-21 1996-04-02 Glaxo Wellcome Inc. Process for forming medicament carrier for dry powder inhalator
US5647347A (en) * 1994-10-21 1997-07-15 Glaxo Wellcome Inc. Medicament carrier for dry powder inhalator
WO1996012515A2 (en) * 1994-10-21 1996-05-02 Glaxo Wellcome Inc. Medicament carrier for dry powder inhalator and process for forming the same
GB9610821D0 (en) * 1996-05-23 1996-07-31 Glaxo Wellcome Inc Metering apparatus
US5871010A (en) * 1996-06-10 1999-02-16 Sarnoff Corporation Inhaler apparatus with modified surfaces for enhanced release of dry powders
GB9616047D0 (en) 1996-07-31 1996-09-11 Glaxo Group Ltd Medicament carrier with agglomerated large medicament particles and related method of manufacture thereof
WO2001094027A2 (en) * 2000-06-05 2001-12-13 Nordson Corporation Apparatus and methods for dispensing minute amounts of liquid
MX2008007977A (en) 2005-12-22 2008-11-14 Philip Morris Prod Inhaler device.
CN108814979B (en) * 2018-04-17 2020-09-22 吉林省中医药科学院 A solid medicine feed ware for paediatrics
CN113650947B (en) * 2021-08-24 2022-10-18 王霞 Accurate medicine bottle of getting of traditional chinese medicine dripping pill

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2837040C2 (en) * 1978-08-24 1982-10-21 Siemens AG, 1000 Berlin und 8000 München Liquid transport system for an inhalation device
ES2087911T3 (en) * 1989-04-28 1996-08-01 Riker Laboratories Inc DRY DUST INHALATION DEVICE.
GB8909891D0 (en) * 1989-04-28 1989-06-14 Riker Laboratories Inc Device

Also Published As

Publication number Publication date
IL98637A0 (en) 1992-07-15
CA2086123A1 (en) 1991-12-29
KR930701206A (en) 1993-06-11
RU2068274C1 (en) 1996-10-27
CZ283510B6 (en) 1998-04-15
NO304295B1 (en) 1998-11-30
HU216129B (en) 1999-04-28
NZ238783A (en) 1994-09-27
EP0536232B1 (en) 1995-09-06
DK0536232T3 (en) 1996-01-22
WO1992000115A1 (en) 1992-01-09
PT98112A (en) 1993-09-30
PT98112B (en) 1998-12-31
FI104410B (en) 2000-01-31
PL165973B1 (en) 1995-03-31
DE59106431D1 (en) 1995-10-12
UA27765C2 (en) 2000-10-16
IE912245A1 (en) 1992-01-01
GR3017782T3 (en) 1996-01-31
FI925882A0 (en) 1992-12-28
FI925882A (en) 1992-12-28
AU661274B2 (en) 1995-07-20
CA2086123C (en) 2002-01-01
EP0536232A1 (en) 1993-04-14
CZ386192A3 (en) 1993-10-13
JP3307389B2 (en) 2002-07-24
ATE127353T1 (en) 1995-09-15
JPH05508334A (en) 1993-11-25
AU8063891A (en) 1992-01-23
SI9111110A (en) 1997-02-28
HU9204100D0 (en) 1993-05-28
ES2078530T3 (en) 1995-12-16
NO925010D0 (en) 1992-12-23
SI9111110B (en) 1999-06-30
NO925010L (en) 1993-01-29
KR0179375B1 (en) 1999-04-01
YU111091A (en) 1994-11-15
IE69035B1 (en) 1996-08-07
HUT63775A (en) 1993-10-28
YU48708B (en) 1999-07-28

Similar Documents

Publication Publication Date Title
JP3130925B2 (en) Powder inhaler, elongate carrier for powdered drug, and cassette with elongate carrier
EP0705614B1 (en) Dry powder inhalation device
AU645788B2 (en) Device
US5460173A (en) Dry powder inhaler medicament carrier
CA2086123C (en) Apparatus and process for metering powder
EP0843566B1 (en) Medicament carrier for dry powder inhalator and process for forming the same
DE4102793A1 (en) Medication powder-dosing carrier

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees